JP2022510436A5 - - Google Patents

Info

Publication number
JP2022510436A5
JP2022510436A5 JP2021531937A JP2021531937A JP2022510436A5 JP 2022510436 A5 JP2022510436 A5 JP 2022510436A5 JP 2021531937 A JP2021531937 A JP 2021531937A JP 2021531937 A JP2021531937 A JP 2021531937A JP 2022510436 A5 JP2022510436 A5 JP 2022510436A5
Authority
JP
Japan
Prior art keywords
formulation
use according
pharmaceutically acceptable
approximately
pentylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021531937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510436A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/051753 external-priority patent/WO2020113340A1/en
Publication of JP2022510436A publication Critical patent/JP2022510436A/ja
Publication of JP2022510436A5 publication Critical patent/JP2022510436A5/ja
Pending legal-status Critical Current

Links

JP2021531937A 2018-12-05 2019-12-05 アルストレーム症候群の治療における２－（３－ペンチルフェニル）酢酸ナトリウムの使用 Pending JP2022510436A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862775849P 2018-12-05 2018-12-05
US62/775,849 2018-12-05
PCT/CA2019/051753 WO2020113340A1 (en) 2018-12-05 2019-12-05 Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome

Publications (2)

Publication Number Publication Date
JP2022510436A JP2022510436A (ja) 2022-01-26
JP2022510436A5 true JP2022510436A5 (https=) 2022-12-08

Family

ID=70973699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531937A Pending JP2022510436A (ja) 2018-12-05 2019-12-05 アルストレーム症候群の治療における２－（３－ペンチルフェニル）酢酸ナトリウムの使用

Country Status (6)

Country Link
US (1) US20220016060A1 (https=)
EP (1) EP3890717A4 (https=)
JP (1) JP2022510436A (https=)
AU (1) AU2019393347A1 (https=)
CA (1) CA3121830A1 (https=)
WO (1) WO2020113340A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2761061A1 (en) * 2009-05-04 2010-11-11 Prometic Biosciences Inc. Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
EA022445B1 (ru) * 2009-05-04 2016-01-29 Прометик Байосайенсиз Инк. Замещенные ароматические соединения, композиции на их основе и их фармацевтические применения
CN105997967B (zh) * 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物

Similar Documents

Publication Publication Date Title
KR101493016B1 (ko) 중약 조성물의 새로운 용도
WO2019024758A1 (zh) 一种糖苷类化合物在制备用于治疗肝纤维化药物中的应用
CN117677395A (zh) 长效glp1/胰高血糖素受体激动剂的剂量方案
CN113952377B (zh) 一种治疗气虚证的中药组合物及其制备方法和用途
CN106177960A (zh) 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途
JP2006514665A5 (https=)
CN101646686A (zh) 铁过剩症的预防或治疗剂
WO2005049043A1 (en) Combination therapy comprising metformin and anticonvulsant agents
US9107930B2 (en) Method for treating unwanted localized fat deposits
Wolf Critical care in the severely burned: organ support and management of complications
JP2022510436A5 (https=)
CN107126434A (zh) 芬戈莫德及其结构类似物用于制备治疗脑出血药物的应用
AU2018446089B2 (en) Pharmaceutical use of anemoside B4 against acute gouty arthritis
JP6454436B1 (ja) ペマフィブラートを含有する医薬
CN114159439B (zh) Dtq在制备高血压治疗药物中的用途及相关产品
WO2024255256A1 (zh) 丙酮酸脱氢酶激酶抑制剂在治疗射血分数保留型心力衰竭中的应用
CN116911513A (zh) 硝唑尼特及其体内代谢物替唑尼特在制备抗心衰药物中的应用
Forster et al. Degenerative changes in cerebral arteries following administration of desoxycorticosterone acetate
CN119564700B (zh) 帕珠沙星甲磺酸盐在制备治疗急性心肌梗死的药物的用途
RU2784896C2 (ru) Медицинское применение анемозида b4 против острого подагрического артрита
CN108403684A (zh) 川陈皮素在制备或筛选糖尿病心肌病药物中的应用
CN120860001A (zh) 肉桂酸在制备用于预防或治疗心肌梗死慢性期病理损伤的药物中的应用
CN116585324A (zh) 前列地尔脂质体预防和/或治疗肾损伤的用途
CN110613525A (zh) 一种慢性心衰急性加重型动物模型的制备方法
CN119950462A (zh) 水芹烯在制备右心室靶向的防治低氧性肺动脉高压药物中的用途